Description
Pfizer Cyklokapron Tranexamic Acid (TXA) for Injection 1,000 mg/10 mL Single-dose Vial 10 mL x 10/Box
Pfizer USPG Cyklokapron Tranexamic Acid for Injection. An injectable form of tranexamic acid is available which is used to improve the surgical outcome in patients with heavy blood loss. Tranexamic acid is a weak fibrinolytic agent that competitively inhibits plasminogen activation, and thereby diminishes the degradation of fibrinogen, plasminogen, and fibrin.
Cyklokapron (Tranexamic acid) is a drug that inhibits the breakdown of fibrinogen, a protein in the blood that helps with clotting. Cyklokapron is used to treat heavy menstrual bleeding and bleeding after childbirth. Cyklokapron is available as a tablet and an injection.
What are the benefits of taking Cyklokapron?
Cyklokapron can help to reduce menstrual bleeding by up to 80%. It can also help to reduce the amount of blood lost after childbirth by up to 50%. Cyklokapron works by stopping the breakdown of fibrinogen, a protein in the blood that is important for clotting. This can help to reduce the risk of heavy bleeding.
CYKLOKAPRON® is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
